---
layout:  post  
title: 合理药物设计
subtitle:  "CADD_Learning"
date:       2017-05-11
author:     "vousmecouter"
header-img: MengYGuo.github.io/img/priscilla-du-preez-181896.jpg

catalog: true
tags: 学习笔记
---

# 合理药物设计


- 1890  lock-and-key model

not take  into account the conformational（构象） change 

- 1958 induced-fit theory

both ligand and target mutually adapt themselves by small conformational changes 

## 1.rational  drug design

three steps: 

1. design of compounds ;
2. molecules are synthesized and tested ;
3. refinement  of a given scaffold and its optimization 

![](https://github.com/MengYGuo/MengYGuo.github.io/blob/master/img/%E6%96%B9%E6%B3%95.JPG?raw=true)

differ method 

- receptor-based drug design(structure-based)

  靶向蛋白已知

- pharmaceutical(药物)-based drug design(ligand(配基) -based)

  靶向蛋白未知，利用活性分子数据

### 1.1.pharmaceutical-based drug design

- pharmaceutical(药物)-based drug design approach
- 基于similarity  concept and molecular  mimicry
- peptidomimetics (模拟肽) 对于肽链分子的mimicking
- 优点：从active molecular开始比从protein structure开始成功的几率更大

### 1.2.receptor-based design 

- 晶体结构揭示了活性位点，用来产生molecular的原型
- 最初有目标蛋白with a ligand的x-ray射线结构，if not，找到相似序列的同源蛋白的x-ray
- 优点：提供了一个可视的框架，可以快速的估算可能的solution的有效性and measure the progress  achieved  in the course of successive  design attempts

### 1.3 integration  in a global perspective 

- typical project 

  ![](https://github.com/MengYGuo/MengYGuo.github.io/blob/master/img/%E6%96%B9%E6%B3%95.JPG?raw=true)

- 两种方法结合在一起产生协同作用

- “binding mode”of the ligand




some point 

pharmacophore-based 药效基团

3D minicry



***

some words

- dopamine 多巴胺
- histamine 组织胺
- estradiol 雌甾二醇
